Healthy stool study aims to sharpen IBD diagnosis
NCT ID NCT07089420
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study measured calprotectin, a protein in stool that signals gut inflammation, in 121 healthy adults aged 22 and older. Participants collected a single stool sample at home and mailed it in. The goal is to establish what level is normal, helping doctors better tell apart inflammatory bowel disease (like Crohn's or colitis) from non-inflammatory conditions like irritable bowel syndrome.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study will give doctors a clearer normal range for calprotectin, making it easier to distinguish inflammatory bowel disease from non-inflammatory conditions.
- What could go wrong
- This is a small, completed study in healthy volunteers only. It does not test a treatment, so it won't directly change patient care until larger studies confirm the findings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN DISEASE (CD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
ALPCO
Salem, New Hampshire, 03079, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a tree mushroom drink calm inflammatory bowel disease?
- Sleep hormone melatonin put to the test for IBD patients with poor sleep
- Which diet do IBD patients prefer? intermittent fasting, mediterranean, or low FODMAP?
- Can better detection of precancerous lesions in IBD prevent colorectal cancer?
- New drug D-2570 aims to quiet Flare-Ups in ulcerative colitis
- Could a postbiotic soothe irritable bowel syndrome?